Abstract:We read with great interest the article by Onuma et al. [1] which evaluated the long-term safety and efficacy of ABSORB bioasorbable everolimus-eluting stent (BVS) scaffold. The investigators of the study have made pioneering contributions to the assessment of bioresorbable scaffolds. It was concluded that sustained safety could be achieved after the implantation of a fully bioresorbable Absorb everolimus-eluting scalffold with a low event rate at 5 years. Besides, the ABSORB Cohort A trial confirmed the feasibility of noninvasive anatomic and functional assessment of the scaffold with the use of multislice computed tomography (MSCT) angiography and MSCT-based fractional flow reserve (FFR) assessment. However, we have several concerns with regard to the study. First, we have to notice that noninvasive FFR analysis was feasible only in 13 patients. The limited size has weakened the reliability of noninvasive FFR performance in assessing functional outcome of ABSORB BVS. Good image quality of all coronary arteries and accurate lumen boundary descriptions are essential for the noninvasive FFR interpretation [2]. Although published reports suggested that CT derived FFR (FFRCT) accuracy was less affected by MSCT image quality than CT stenosis [3], there were four patients (22.2%) who cannot have FFRCT analysis due to severe artifact. Besides, in those with feasible FFRCT, numerous artifacts including calcification, motion, and misregistration may also affect MSCT performance and lead to inaccurate anatomic models for FFRCT computation [4]. Thus, the feasibility and precision of FFRCT need to be further improved. It is not appropriate to use FFRCT alone as a hemodynamic parameter in functional coronary stenosis measurement. Second, a fly in the ointment of the study was the absence of invasive FFR as a reference against noninvasive FFRCT at 5 years. Despite Onuma et al. demonstrated several reasons that they decided to perform repeat MSCT alone instead of invasive imaging, we cannot deny the fact that no published convincing trial exists for FFRCT in the evaluation of interventional treatment [4], although the DISCOVER-FLOW study [5] validated that the FFRCT had a good correlation with an invasive FFR, and the DeFACTO trial [6] demonstrated that the FFRCT plus CT was superior to CT alone as a measure of coronary computed tomography angiography (CCTA) stenosis severity for determination of lesion-specific ischemia. Finally, in the study, angiographic reference standard of the vessel lumen area was derived from MSCT analysis instead of invasive coronary angiography [1]. It is important, however, to note that there is an overestimation of stenosis severity identified by CCTA and even among severe stenosis confirmed by invasive coronary angiography, only a minority cause ischemia [4,6]. Therefore, the possible deviation resulted from the inaccurate reference of MSCT may make the results less convincible.

Diagnostic Accuracy of Intracoronary Optical Coherence Tomography-Derived Fractional Flow Reserve for Assessment of Coronary Stenosis Severity.

Diagnostic Performance of Angiography-Based Fractional Flow Reserve for Functional Evaluation of Coronary Artery Stenosis

Diagnostic Accuracy of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve

Diagnostic Performance of Angiography-Based Fractional Flow Reserve for Functional Evaluation of Coronary Artery Stenosis.

Diagnostic Performance of Intracoronary Optical Coherence Tomography-Based Versus Angiography-Based Fractional Flow Reserve for the Evaluation of Coronary Lesions.

Diagnostic accuracy of a novel optical coherence tomography-based fractional flow reserve algorithm for assessment of coronary stenosis significance

Diagnostic Performance of Computational Fluid Dynamics (Cfd)-Based Fractional Flow Reserve (FFR) Derived from Coronary Computed Tomographic Angiography (CCTA) for Assessing Functional Severity of Coronary Lesions

TCT-343 Diagnostic Accuracy and Reproducibility of Optical Coherence Tomography–Based Fractional Flow Reserve for Functional Evaluation of Coronary Stenosis

TCT-40 Diagnostic Accuracy of Intracoronary Optical Coherence Tomography-Based Quantitative Flow Ratio for Assessment of Coronary Stenosis

Diagnostic Performance of AccuFFRangio in the Functional Assessment of Coronary Stenosis Compared with Pressure Wire-Derived Fractional Flow Reserve.

Diagnostic accuracy and reproducibility of optical flow ratio for functional evaluation of coronary stenosis in a prospective series

Comprehensive Assessment Of Coronary Fractional Flow Reserve

Diagnostic Accuracy of Optical Flow Ratio: an Individual Patient Data Meta-Analysis

Accuracy of Intravascular Ultrasound-Based Fractional Flow Reserve in Identifying Hemodynamic Significance of Coronary Stenosis

Diagnostic Performance of Intracoronary Optical Coherence Tomography-Modulated Quantitative Flow Ratio for Assessing Coronary Stenosis

Safety and Efficacy of a Novel Technique in the Use of Fractional Flow Reserve in Complex Coronary Artery Lesions.

Challenges in Multislice Computed Tomography Based Fractional Flow Reserve to Evaluate Interventional Treatment

Optical Flow Ratio for Assessing Stenting Result and Physiological Significance of Residual Disease

A comparative study of optimization algorithm FFR-CT and invasive FFR

Computed Tomography-Derived Fractional Flow Reserve in the Detection of Lesion-Specific Ischemia

Diagnostic performance of fractional flow reserve derived from coronary angiography, intravascular ultrasound, and optical coherence tomography; a meta-analysis